Click sobre imagen para ampliar
The most advertised brand in the first part of 2011 was an established product—Lilly’s Cymbalta.
Otherwise, the top 10 was mostly all Forest: Teflaro, Lexapro and Savella took the next three spots, and Forest brands Bystolic and Viibryd made eight and nine.
Two pain drugs—J&J’s Nucynta and Purdue’s Butrans—burst onto the scene at numbers five and six, followed by top-10 incumbent Humalog.
Another newcomer, Takeda’s Dexilant, rounded out the list.
(Ver)
Ver también:
No hay comentarios:
Publicar un comentario